Back to AL Alphabet Inc.
QNCX
27 quarters
Position history for ALAlphabet Inc.'s holdings in QUINCE THERAPEUTICS INC
No. Alphabet exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 189,122 shares worth $633,559. Alphabet already held QNCX in its Q3 2019 13F, the earliest on record, and held it in 26 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$7.8M
Total Shares Change
-312,102
Quarter-by-Quarter History
Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors